Live Status Check

NCT04939610 Recruiting Status

Real-time enrollment status for this solid tumor clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: March 2, 2026 at 1:39 PM UTC

NCT04939610 Status Summary

NCT NumberNCT04939610
Recruiting StatusRecruiting
ConditionSolid Tumor
PhaseClinical Trial
Target Enrollment222 participants
Active Locations18 sites in the US
SponsorNovartis Pharmaceuticals
Last Updated on CT.govJanuary 27, 2026 (Jan 27, 2026)

About NCT04939610 Enrollment Status

As of March 2, 2026: Clinical trial NCT04939610 is currently recruiting participants. This clinical trial study for solid tumor is actively seeking new participants at 18 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT04939610

Is NCT04939610 still recruiting?

Yes, NCT04939610 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT04939610 recruiting?

This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT04939610?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT04939610 status last updated?

The official ClinicalTrials.gov record for NCT04939610 was last updated Jan 27, 2026 (January 27, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial